Opioid Use Disorder Guideline

Algorithm

mOUD Algorithm
Descriptive text is not available for this image
Initial Inpatient Management of Opioid Use Disorder in Pregnancy or Labor

Case

A 25-year-old G1P0 at 32 weeks gestation presents to the obstetric ED acutely withdrawing from opioids.

Assessment

What do you need to consider for opioid use disorder?

  1. Is she actually withdrawing? If so, can we initiate buprenorphine treatment?
  2. Symptoms of withdrawl: lacrimation or rhinorrhea, piloerection "goose flesh", myalgia, diarrhea, nausea/vomiting, pupillary dilation, photophobia, insomnia, autonomic hyperactivity (tachypnea, hyperreflexia, tachycardia, sweating, hypertension, hyperthermia), and yawning.
  3. Admit to an inpatient unit
  4. Obtain a thorough history including what substances, last use, and route of use
  5. If unable to obtain a history or it is incongruent with presentation, consider urine drug screen (patient consent may be required; highly recommended; check hospital policy)
  6. Assess vitals, to include COWS score[1]
  7. COWS > or = 8 AND one objective finding of withdrawal
  8. Physical exam
  9. Labs: Urine drug screen (consent), LFTs, STI testing
  10. Non-Stress Test if ≥ 23-24 weeks
  11. Assess their intent to continue using opioids versus starting medication assisted therapy (MAT)
  12. If they want to start MAT, obtain written CONSENT/CONTRACT PRIOR TO INDUCTION

Treatment

If opioids (fentanyl) and want to continue using:

  1. Replace their opioid
    1. hydromorphone 4-8 mg PO q 1-2 hrs PRN
    2. You will likely need to increase that dose so do not hesitate to go up if necessary (up to 8-12 mg PO q 1 hr PRN)

If opioids (fentanyl) and want to start Medication Assisted Therapy (MAT):

  1. With methadone (time of last use doesn’t matter)
    1. Get an EKG to evaluate QTs interval (consider buprenorphine if QTC > 500)
    2. Day 1: methadone 40 mg and in 4 hrs repeat 20 mg PRN x1
    3. Day 2: methadone 60 mg and in 4 hrs repeat 20 mg PRN x1
    4. Day 3: methadone 80 mg and in 4 hrs repeat 20 mg PRN x1
    5. Day 4: methadone 100 mg. Obtain a second EKG for QTc interval
    6. Opioid replacement during this induction of methadone
    7. Will need referral to an approved methadone treatment clinic
  2. With buprenorphine (if less than 24 hours since last use)
    1. Start with micro-induction:
      1. Buprenorphine 0.5 mg SL q 4 hrs for 24 hrs
      2. Then buprenorphine 1 mg SL q 4 hrs x 24 hrs
      3. Then buprenorphine 2 mg SL q 4 hrs x 24 hrs
      4. Opioid replacement during this induction of buprenorphine.
  3. Adjunctive medications for withdrawal (usually 4-12 hrs after last use):
    1. Clonidine 0.1 mg PO q 6 hrs prn
    2. Gabapentin 300 mg PO q 6 hrs prn
    3. Cyclobenzaprine 5-10 mg q 8 hrs prn
      1. Can use Tizanidine 4 mg PO q hrs prn, discuss feeding plans w/patient as it is an L4 med
    4. Hydroxyzine 25-50 mg PO q 6 hrs prn

Post-operative management in the first 24 hrs

  1. Consider continuous epidural x 24 hrs
  2. Consider TAP block by anesthesia
  3. Multimodal pain mgmt: APAP, ketorolac, opioids if necessary

If > 24 hours since last use, follow BRIDGE protocol for buprenorphine start. Can use either Suboxone® (Buprenorphine / Naloxone) or Subutex® buprenorphine) in pregnancy.

  1. Start buprenorphine 8mg sublingual
  2. Rescore COWS q 1 - 1.5 hours and redose Suboxone 4mg SL q 1 - 1.5 hours: GOAL IS 80% REDUCTION OR SCORE < 5.
    TOTAL MAX DOSE OF 12mg ON DAY 1
  3. NST prior to discharge if ≥ 23-24 weeks
  4. Rx provided for total dose given on induction day (NOTE ALL SUBOXONE SCRIPTS MUST BE WRITTEN AS q DAY DOSING)

Multidisciplinary team care model

  1. Team to include social workers, psychiatry, MFM, addiction resources in your area.
  2. Local outpatient referral centers, suggest biannual review of local resources to keep up to date.
    1. Example: Nexus Recovery https://nexusrecovery.org/
      1. Residential, medical, psychiatry, outpatient, childhood development center

Clinical Considerations

  1. Avoid Nubain and Stadol (partial antagonist and can put patient in withdrawal)
  2. Consider use of TAP/QL blocks, enhanced recovery pathways with around the clock Tylenol 1000mg q6 hours/Ibuprofen 600mg q6 hours
  3. Pain management post cesarean section, shared decision making with patient. Opioid dependent patients require higher doses.
  4. Discharge home with Narcan, link to goodrx.com for free Narcan kits
  5. FDA has now approved Narcan nasal spray[2]

Other Considerations for Management

Links to Useful Clinical Resources

Comprehensive Toolkits

CA Bridge Treatment Protocols

CQMCC (California Maternal Quality Care Collaborative)

OUD Clinical Care Checklist example. CMQCC referencing Illinois

MCPAP for Moms Complete Toolkit (Massachusetts Child Psychiatry Access Program) Substance abuse disorders and pernatal mental health

Notable association guidelines

References

  1. Wesson DR, Ling W. The Clinical Opiate Withdrawal Scale (COWS). J Psychoactive Drugs. 2003;35(2):253-9.  [PMID:12924748]
  2. Commissioner, Office of the. “FDA Approves First Over-the-Counter Naloxone Nasal Spray.” FDA. FDA, March 29, 2023.



Last updated: August 12, 2024